Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
SERB Pharmaceuticals to acquire development and commercialisation rights to Idefirix® (imlifidase) in Europe and MENA from Hansa Biopharma for €115 million
-
Austin, TX, USA, May 19, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Cholera Vaccine Market Size, Trends and Insights By Type (Whole Cell v. Cholerae...
-
Alaunos reports preclinical ALN1003 data showing effects on insulin resistance biomarkers and liver histology in obesity mouse models.
-
Austin, TX, USA, May 13, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Intravenous (IV) Fluid Bags Market Size, Trends and Insights By Material Type (PVC...
-
Austin, TX, USA, May 06, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “RNA Targeting Small Molecule Drug Discovery Market Size, Trends and Insights By...
-
A 20-year CT imaging archive that global researchers couldn't effectively search. Starfish turned weeks-long data requests into minutes.
-
Austin, TX, USA, May 05, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Targeted DNA RNA Sequencing Market Size, Trends and Insights By Technology (NGS,...
-
UPDATED: NorthStrive Biosciences Files New U.S. Patent Application Covering EL-22 Formulations and Dosing for Treatment of Muscle-Wasting Conditions relate
-
Austin, TX, USA, April 29, 2026 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Generative AI in Chemical Market Size, Trends and Insights By Component...
-
BRANFORD, Conn., April 28, 2026 (GLOBE NEWSWIRE) -- EvolveImmune Therapeutics, a clinical-stage immuno-oncology company developing a new class of multi-specific T cell engagers with integrated CD2...